Publication | Closed Access

Effects of LX4211, a Dual Sodium-Dependent Glucose Cotransporters 1 and 2 Inhibitor, on Postprandial Glucose, Insulin, Glucagon-like Peptide 1, and Peptide Tyrosine Tyrosine in a Dose-Timing Study in Healthy Subjects

Metabolic SyndromeMolecular PharmacologyHealthy SubjectsMedicineDiabetesPhysiologyPeptide Tyrosine TyrosineDose-timing StudyPharmacotherapyDiabetes MellitusPharmacologyInsulin SignalingHealth Sciences